Committed to providing exceptional care and continued support to patients, families and caregivers.

Menu

NCT02639182

Disease Type: Gastrointestinal
Status: Open

Trial Information

A Multi-center, Open Label, Randomized Phase II Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma

Click here for more information

This trial is available at:

Midwest Cancer Center – Legacy
17201 Wright Street, Suite 200, Omaha, NE 68130
Phone: 402-334-4773
Fax: 402-330-7463

For more information, please contact: